STAT3 inhibitors
US11026905B2 · kind B2 · utility
3Cited by
6References
6Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Oct 22, 2020 |
| Grant date | Jun 8, 2021 |
| Priority date | — |
| Expiry date | Oct 22, 2040 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds as STAT3 inhibitors are described. A pharmaceutical composition comprising the same, methods of making the same, and a method for treating or preventing conditions such as cancer, chronic inflammation, and fibrosis using the same, are described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.